We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.
BDSI

Delisted

BDSI was delisted on the 22nd of March, 2022.

Back to rankings

2 hedge funds and large institutions have $26K invested in BioDelivery Sciences International, Inc. in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 152 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,033% more call options, than puts

Call options by funds: $34K | Put options by funds: $3K

99% less funds holding

Funds holding: 156 → 2 (-154)

100% less capital invested

Capital invested by funds: $181M → $26K (-$181M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 152

Holders
2
Holders Change
-154
Holders Change %
-98.72%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
152
Calls
$34K
Puts
$3K
Net Calls
+$31K
Net Calls Change
-$4.72M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$22.6M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$14.7M
3
SFM
Systematic Financial Management
New Jersey
-$13.5M
4
LSV Asset Management
LSV Asset Management
Illinois
-$10.9M
5
RA
Royce & Associates
New York
-$7.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
126
Meeder Asset Management
Ohio
– -$42K -13,385 Closed
Credit Agricole
127
Credit Agricole
France
– -$40K -12,923 Closed
Zurich Cantonal Bank
128
Zurich Cantonal Bank
Switzerland
– -$40K -12,792 Closed
Millennium Management
129
Millennium Management
New York
– -$38K -12,255 Closed
PAG
130
Private Advisor Group
New Jersey
– -$33K -10,800 Closed
Osaic Holdings
131
Osaic Holdings
Arizona
– -$31K -10,096 Closed
GF
132
Gabelli Funds
New York
– -$31K -10,000 Closed
AIP
133
Ameritas Investment Partners
Nebraska
– -$22K -7,195 Closed
Canada Life
134
Canada Life
Manitoba, Canada
– -$18K -5,699 Closed
MIM
135
MetLife Investment Management
New Jersey
– -$15.6K -5,018 Closed
JFGIW
136
Johnson Financial Group Inc (Wisconsin)
Wisconsin
– -$16K -5,000 Closed
CA
137
CoreCap Advisors
Michigan
– -$13K -4,193 Closed
TRCT
138
Tower Research Capital (TRC)
New York
– -$12K -3,972 Closed
EARNEST Partners
139
EARNEST Partners
Georgia
– -$9K -2,800 Closed
PHK
140
Point72 Hong Kong
Hong Kong
– -$7K -2,380 Closed
CAPTRUST Financial Advisors
141
CAPTRUST Financial Advisors
North Carolina
– -$6K -2,080 Closed
TWM
142
Tradition Wealth Management
Minnesota
– -$6K -2,000 Closed
AA
143
Ancora Advisors
Ohio
– -$3K -1,000 Closed
DI
144
Disciplined Investments
Oklahoma
– -$3K -1,000 Closed
Fidelity Investments
145
Fidelity Investments
Massachusetts
– -$3K -1,000 Closed
AA
146
AlphaMark Advisors
Kentucky
– -$1K -400 Closed
IA
147
IFP Advisors
Florida
– -$1K -250 Closed
Daiwa Securities Group
148
Daiwa Securities Group
Japan
– -$1K -222 Closed
AW
149
Avion Wealth
Texas
– -$1K -200 Closed
US Bancorp
150
US Bancorp
Minnesota
– -$1K -200 Closed
3 4 5
6
7

BDSI Hedge Fund Activity: Q1 2022 in Review

2 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q1 2022, worth a combined $26K — down 100% from $181M a quarter earlier.

Sellers outnumbered buyers: 152 funds closed out of BDSI and 0 opened new positions — a net loss of 152 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $22.6M sold.

  • 2 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q1 2022, down from 156 in Q4 2021.
  • Funds reported $26K of BioDelivery Sciences International, Inc. stock for Q1 2022, down 100% quarter-over-quarter.
  • 0 funds opened new BioDelivery Sciences International, Inc. positions in Q1 2022 and 152 closed out, a net change of -152 holders.
  • The largest BioDelivery Sciences International, Inc. seller in Q1 2022 was BlackRock, an estimated $22.6M sold.

Based on aggregated 13F filings for Q1 2022.